Rhumbline Advisers Legend Biotech Corp Transaction History
Rhumbline Advisers
- $121 Billion
- Q3 2025
A detailed history of Rhumbline Advisers transactions in Legend Biotech Corp stock. As of the latest transaction made, Rhumbline Advisers holds 20,222 shares of LEGN stock, worth $612,524. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,222
Previous 27,349
26.06%
Holding current value
$612,524
Previous $970,000
32.06%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding LEGN
# of Institutions
223Shares Held
57.2MCall Options Held
231KPut Options Held
626K-
Westfield Capital Management CO LP Boston, MA6.09MShares$185 Million0.91% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$181 Million5.86% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$173 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.82MShares$116 Million3.74% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$89.7 Million1.8% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.07B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...